DOLOXE

data insights

Key Feature

HEOR Tracker

Provides integrated intelligence on drug pricing, reimbursement, HTA, therapy cost, and international reference pricing (IRP) . It enables evidence-based market access decisions, payer negotiations, and global benchmarking for sustainable healthcare strategies.

Request Demo →
HEOR Tracker

Key Features of HEOR Tracker Platform

1. Drug Pricing & Reimbursement Intelligence

  • Comprehensive Pricing Database: Centralized repository of global drug list prices, net prices, and negotiated discounts.
  • Reimbursement Pathway Mapping: Country-specific reimbursement processes, payer requirements, and timelines.
  • Scenario Modeling: Simulates impact of price changes, rebates, and policy shifts on market access outcomes.

2. Health Technology Assessment (HTA) Integration

  • HTA Dossier Builder: Automated templates aligned with major agencies (NICE, HAS, IQWiG, CADTH, ICER).
  • Comparative Evidence Frameworks: Synthesizes clinical, economic, and patient-reported outcomes for HTA submissions.
  • Decision Tracking: Monitors HTA outcomes across geographies to benchmark success rates and payer trends.

3. Therapy Cost & Budget Impact Analysis

  • Cost-of-Therapy Models: Calculates per-patient and population-level therapy costs across treatment lines.
  • Budget Impact Tools: Forecasts payer expenditure under different adoption scenarios.
  • Value-Based Pricing Analytics: Aligns therapy cost with clinical benefit and QALY thresholds.

4. International Reference Pricing (IRP)

  • Global Benchmarking Engine: Tracks IRP rules across 50+ markets, including basket composition and calculation methods.
  • Launch Sequencing Simulator: Models how pricing in one country affects reference-linked markets.
  • Risk Alerts: Flags exposure to spillover effects when U.S. MFN, EU IRP, or regional reference pricing policies overlap.

5. Strategic Insights & Visualization

  • Executive Dashboards: Interactive visuals for pricing trends, HTA decisions, and therapy cost comparisons.
  • Scenario Planning: "What-if" simulations for policy changes (e.g., MFN, inflation rebates, tariff impacts).
  • Stakeholder Messaging: Tailored outputs for payers, regulators, and internal leadership.

Benefits for Healthcare Players

Evidence-Based Pricing:
  • Offers robust drug pricing and reimbursement intelligence to support payer negotiations and formulary inclusion.
HTA Alignment:
  • Streamlines submissions with comparative evidence frameworks, ensuring smoother regulatory and payer approvals.
Budget Impact Analysis:
  • Equips healthcare systems with tools to forecast therapy costs and manage financial sustainability.
Global Benchmarking:
  • Provides international reference pricing insights, enabling healthcare players to anticipate cross-border pricing pressures.